Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis
Read the article on our ERC grant “Clostridium-based Immunotherapy” which has been published on the CORDIS website in six languages at: https://lnkd.in/g5AQSvR
Exploiting recombinant Clostridium for precise delivery of immnotherapeutics to solid tumours
Summary: The use of immune modulating agents to “wake up” the immune system in patients is a remarkable breakthrough in cancer treatment and was recently recognised […]
Approval of second European COVID-19 project for PM.
A second European project on COVID-19 research, AI for imaging: « i covid », has been approved for Precision Medicine»
Obtaining research grants in times of corona
In this Zoom-interview, Prof. Philippe Lambin, speaks about the research of his Department of Precision Medicine, that obtained over three million euros of research funding in […]
Podcast in British Journal of Radiology to celebrate their 125th anniversary! Radiomics: from qualitative to quantitative imaging — an interview with BJR author Professor Philippe Lambin
In this podcast, we speak to Professor Philippe Lambin, Head of the Department of Precision Medicine at the University of Maastricht, The Netherlands, and author of […]
